The EU Commission conditionally clears a merger in the pharmaceutical industry (Novartis / Alcon)

"Mergers: main developments between 1 May and 31 August 2010"* On 9 August the Commission approved the proposed acquisition of Alcon by Novartis, both pharmaceutical companies based in Switzerland. The decision is conditional upon Novartis‘ commitments to divest several products in the ophthalmological

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • JG Associates (Brussels)

Quotation

John Gatti, The EU Commission conditionally clears a merger in the pharmaceutical industry (Novartis / Alcon), 9 August 2010, e-Competitions Bulletin August 2010, Art. N° 37440

Visites 624

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues